AstraZeneca pledges $150 million for production facility in Russia
This article was originally published in Scrip
AstraZeneca's division in Russia has announced that the company will invest $150 million in the construction of a full-cycle production facility in Vorsino near Kaluga, a city 150 kilometres south-west of Moscow.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.